DNA topoisomerase inhibitors.
Capranico
G
G
Instituto Nazionale per lo Studio e la Cura dei Tumori, Milano, Italy.
Giaccone
G
G
Zunino
F
F
Garattini
S
S
D'Incalci
M
M
D000818:Animals; D002166:Camptothecin / Q000031:analogs & derivatives / Q000494:pharmacology / Q000627:therapeutic use; D004264:DNA Topoisomerases, Type I / Q000235:genetics; D004250:DNA Topoisomerases, Type II / Q000235:genetics; D004347:Drug Interactions; D004351:Drug Resistance; D005047:Etoposide / Q000494:pharmacology / Q000633:toxicity; D006801:Humans; D000077146:Irinotecan; D059004:Topoisomerase I Inhibitors; D059005:Topoisomerase II Inhibitors; D019772:Topotecan
D059004:Topoisomerase I Inhibitors; D059005:Topoisomerase II Inhibitors; D005047:Etoposide; D000077146:Irinotecan; D019772:Topotecan; D004264:DNA Topoisomerases, Type I; D004250:DNA Topoisomerases, Type II; D002166:Camptothecin